|2012.10.26||MEDIAArticle on human ES/iPSC-derived Cardiomyocytes published
An article written jointly by Kyoto University and ReproCELL was published in Cell Rep. 2012 Nov 29;2(5):1448-60.. “Small Molecule that Promotes Cardiac Differentiation of Human Pluripotent Stem Cells under Defined, Cytokine- and Xeno-free Conditions”
|2012.10.17||Deloitte Technology Fast 50 Japan Award
ReproCELL was awarded Deloitte Technology Fast 50 Japan 2012.
|2012.10.11||MEDIAReproCELL’s iPS cell business introduced in Japanese TV news programs
ReproCELL’s iPS cell business was widely introduced in Japanese TV news on Prof. Shinya Yamanaka’s Nobel Prize.
|2012.10.09||2012 Nobel Prize in Physiology or Medicine
The 2012 Nobel Prize in Physiology or Medicine was awarded jointly to Prof. John B. Gurdon and Prof. Shinya Yamanaka “for the discovery that mature cells can be reprogrammed to become pluripotent”.
|2012.07.11||PRODUCTThin layer cardiomyocyte protocols released
New application protocols for thin layered ReproCardio2 (cardiomyocytes derived from human iPS cells) are now available. Please visit the web page below for the details and requesting the protocol. – MEA recordings from beating thin layer formed by ReproCardio 2 – Live imaging of calcium concentration change using ReproCardio 2 thin layer
|2012.07.11||PRODUCTNew product information (Alzheimer’s disease model, Ach neurons)
We have uploaded information about our new products of ReproNeuro, human iPSC-derived neurons. Please visit the webpage below for the details. ReproNeuro Ach Kit and Alzheimer’s Disease Model Cells Disease model neurons for Alzheimer’s disease research, and cholinergic neurons derived from human iPS cells.
|2012.06.09||PRODUCTReproCELL launches Alzheimer’s disease model based on iPS-derived human neuronal cells
Yokohama, Kanagawa, Japan - ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) announces today that the company will start commercializing human iPS-derived neurons in which an Alzheimer’s disease related gene has been incorporated. ReproCELL’s scientists have successfully incorporated a gene related to Alzheimer’s disease using homologous recombinant genetic engineering technology into undifferentiated human iPS cells and then differentiated them into neurons. In these cells, it has been confirmed that amyloid beta 42 is accumulated at higher levels compared to normal neurons. This phenomena is similar to what is observed in neurons of Alzheimer’s patients. Accordingly, ReproCELL’s scientists believe the newly developed iPS cells can be useful for drug screening to identify new […]
|2012.04.23||Holiday closure of ReproCELL headquarters
ReproCELL headquarters in Japan closes on the dates below, for Japanese spring holiday season. April 30th May 3rd, 4th US subsidiary and UK office won’t be affected, and will be operating as usual.
|2012.02.01||PRODUCTInstruction movies for human iPSC culture procedure
Instruction movies for human iPS cell culture procedure are now available on our website.
|2012.01.18||MEDIAGEN article introduced ReproCELL’s technology
ReproCELL’s iPS cell-derived cardiomyocytes, neurons and hepatocytes were introduced in Genetic Engineering & Biotechnology News (GEN). Jan 15, 2012 (Vol. 32, No. 2) Stem Cell Applications Hasten into the Clinic